
U.S. Centers Seek Namodenoson for Pancreatic Cancer Compassionate Use
Medical centers in the U.S. are seeking compassionate use approval from the U.S. Food and Drug Administration (FDA) for Namodenoson in the treatment of patients with pancreatic carcinoma, according to a news release from Can-Fite BioPharma Ltd. …